Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind study

BACKGROUND/AIMS: This study assessed the efficacy and safety of high-dose multimatrix mesalazine once-daily (QD) compared to another form of high-dose mesalazine. METHODS: In this multicenter, randomized, double-blind study, 280 patients with mildly to moderately active ulcerative colitis (UC) recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogata, Haruhiko, Aoyama, Nobuo, Mizushima, Seiichi, Hagino, Atsushi, Hibi, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478762/
https://www.ncbi.nlm.nih.gov/pubmed/28670234
http://dx.doi.org/10.5217/ir.2017.15.3.368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478762/
https://www.ncbi.nlm.nih.gov/pubmed/28670234
http://dx.doi.org/10.5217/ir.2017.15.3.368

Ejemplares similares